Low expression of CDK5RAP3 and DDRGK1 indicates a poor prognosis in patients with gastric cancer

about

Low expression of CDK5RAP3 and DDRGK1 indicates a poor prognosis in patients with gastric cancer

Item

http://www.wikidata.org/entity/Q58740361

description

im September 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Low expression of CDK5RAP3 and ...... n patients with gastric cancer

@en

Low expression of CDK5RAP3 and ...... n patients with gastric cancer

@nl

type

Item

label

Low expression of CDK5RAP3 and ...... n patients with gastric cancer

@en

Low expression of CDK5RAP3 and ...... n patients with gastric cancer

@nl

prefLabel

Low expression of CDK5RAP3 and ...... n patients with gastric cancer

@en

Low expression of CDK5RAP3 and ...... n patients with gastric cancer

@nl

P1476

Low expression of CDK5RAP3 and ...... n patients with gastric cancer

@en

P2093

Chang-Ming Huang

http://www.w3.org/2001/XMLSchema#string

Chao-Hui Zheng

http://www.w3.org/2001/XMLSchema#string

Jia-Bin Wang

http://www.w3.org/2001/XMLSchema#string

Jian-Wei Xie

http://www.w3.org/2001/XMLSchema#string

Jian-Xian Lin

http://www.w3.org/2001/XMLSchema#string

Jun Lu

http://www.w3.org/2001/XMLSchema#string

Long-Long Cao

http://www.w3.org/2001/XMLSchema#string

Mi Lin

http://www.w3.org/2001/XMLSchema#string

Ping Li

http://www.w3.org/2001/XMLSchema#string

Qi-Yue Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of a common protein association region in the neuronal Cdk5 activator

A novel type of E3 ligase for the Ufm1 conjugation system

DDRGK1 regulates NF-κB activity by modulating IκBα stability

A novel C53/LZAP-interacting protein regulates stability of C53/LZAP and DDRGK domain-containing Protein 1 (DDRGK1) and modulates NF-kappaB signaling

Modification of ASC1 by UFM1 is crucial for ERα transactivation and breast cancer development

Suppression of the novel ER protein Maxer by mutant ataxin-1 in Bergman glia contributes to non-cell-autonomous toxicity

LZAP inhibits p38 MAPK (p38) phosphorylation and activity by facilitating p38 association with the wild-type p53 induced phosphatase 1 (WIP1)

LZAP, a putative tumor suppressor, selectively inhibits NF-kappaB

Overexpression of a novel activator of PAK4, the CDK5 kinase-associated protein CDK5RAP3, promotes hepatocellular carcinoma metastasis

Ubiquitin fold modifier 1 (UFM1) and its target UFBP1 protect pancreatic beta cells from ER stress-induced apoptosis

P304

3898-3907

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V24.I34.3898

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-09-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30228783

http://www.w3.org/2001/XMLSchema#string

P921

gastroenterology

P932

6141336

http://www.w3.org/2001/XMLSchema#string